Dr. Carter acknowledges that this is an X-factor in the ARRA process. “We say thanks to Congress for allowing us to do something really special, but there is no question that there may be problems two years from now.”
You Might Also Like
Explore This IssueOctober 2009
Nevertheless, rheumatology researchers are making good use of the ARRA funds to launch new research projects, support ongoing investigations, and create partnerships and consortia to further understanding of rheumatic disease.
Kurt Ullman is a freelance writer based in Indiana.